Literature DB >> 10677517

Mitochondrial carbonic anhydrase CA VB: differences in tissue distribution and pattern of evolution from those of CA VA suggest distinct physiological roles.

G N Shah1, D Hewett-Emmett, J H Grubb, M C Migas, R E Fleming, A Waheed, W S Sly.   

Abstract

A cDNA for a second mouse mitochondrial carbonic anhydrase (CA) called CA VB was identified by homology to the previously characterized murine CA V, now called CA VA. The full-length cDNA encodes a 317-aa precursor that contains a 33-aa classical mitochondrial leader sequence. Comparison of products expressed from cDNAs for murine CA VB and CA VA in COS cells revealed that both expressed active CAs that localized in mitochondria, and showed comparable activities in crude extracts and in mitochondria isolated from transfected COS cells. Northern blot analyses of total RNAs from mouse tissues and Western blot analyses of mouse tissue homogenates showed differences in tissue-specific expression between CA VB and CA VA. CA VB was readily detected in most tissues, while CA VA expression was limited to liver, skeletal muscle, and kidney. The human orthologue of murine CA VB was recently reported also. Comparison of the CA domain sequence of human CA VB with that reported here shows that the CA domains of CA VB are much more highly conserved between mouse and human (95% identity) than the CA domains of mouse and human CA VAs (78% identity). Analysis of phylogenetic relationships between these and other available human and mouse CA isozyme sequences revealed that mammalian CA VB evolved much more slowly than CA VA, accepting amino acid substitutions at least 4.5 times more slowly since each evolved from its respective human-mouse ancestral gene around 90 million years ago. Both the differences in tissue distribution and the much greater evolutionary constraints on CA VB sequences suggest that CA VB and CA VA have evolved to assume different physiological roles.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10677517      PMCID: PMC26495          DOI: 10.1073/pnas.97.4.1677

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  A simplified micromethod for the determination of carbonic anhydrase and its inhibitors.

Authors:  T H MAREN
Journal:  J Pharmacol Exp Ther       Date:  1960-09       Impact factor: 4.030

2.  Carbonic anhydrase II deficiency: diagnosis and carrier detection using differential enzyme inhibition and inactivation.

Authors:  V Sundaram; P Rumbolo; J Grubb; P Strisciuglio; W S Sly
Journal:  Am J Hum Genet       Date:  1986-02       Impact factor: 11.025

3.  Isolation of mammalian mitochondrial DNA and RNA and cloning of the mitochondrial genome.

Authors:  D P Tapper; R A Van Etten; D A Clayton
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

4.  Phylogenetic origins and adaptive evolution of avian and mammalian haemoglobin genes.

Authors:  J Czelusniak; M Goodman; D Hewett-Emmett; M L Weiss; P J Venta; R E Tashian
Journal:  Nature       Date:  1982-07-15       Impact factor: 49.962

Review 5.  Decoding the pattern of protein evolution.

Authors:  M Goodman
Journal:  Prog Biophys Mol Biol       Date:  1981       Impact factor: 3.667

6.  Measurement of carbonic anhydrase activity inside cells and subcellular particles.

Authors:  R E Forster; S J Dodgson; B T Storey; L Lin
Journal:  Ann N Y Acad Sci       Date:  1984       Impact factor: 5.691

7.  The role of carbonic anhydrase in hepatocyte metabolism.

Authors:  S J Dodgson; R E Forster; B T Storey
Journal:  Ann N Y Acad Sci       Date:  1984       Impact factor: 5.691

8.  A simplification of the protein assay method of Lowry et al. which is more generally applicable.

Authors:  G L Peterson
Journal:  Anal Biochem       Date:  1977-12       Impact factor: 3.365

9.  Functional diversity, conservation, and convergence in the evolution of the alpha-, beta-, and gamma-carbonic anhydrase gene families.

Authors:  D Hewett-Emmett; R E Tashian
Journal:  Mol Phylogenet Evol       Date:  1996-02       Impact factor: 4.286

10.  High level transient expression of a chloramphenicol acetyl transferase gene by DEAE-dextran mediated DNA transfection coupled with a dimethyl sulfoxide or glycerol shock treatment.

Authors:  M A Lopata; D W Cleveland; B Sollner-Webb
Journal:  Nucleic Acids Res       Date:  1984-07-25       Impact factor: 16.971

View more
  28 in total

Review 1.  Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding.

Authors:  Vijay M Krishnamurthy; George K Kaufman; Adam R Urbach; Irina Gitlin; Katherine L Gudiksen; Douglas B Weibel; George M Whitesides
Journal:  Chem Rev       Date:  2008-03       Impact factor: 60.622

Review 2.  Carbonic anhydrases as disease markers.

Authors:  Sabina Zamanova; Ahmed M Shabana; Utpal K Mondal; Marc A Ilies
Journal:  Expert Opin Ther Pat       Date:  2019-06-17       Impact factor: 6.674

3.  Expression profile of carbonic anhydrases in articular cartilage.

Authors:  Melissa Schultz; Wu Jin; Abdul Waheed; Berton R Moed; William Sly; Zijun Zhang
Journal:  Histochem Cell Biol       Date:  2011-07-08       Impact factor: 4.304

4.  Extramitochondrial domain rich in carbonic anhydrase activity improves myocardial energetics.

Authors:  Marie A Schroeder; Mohammad A Ali; Alzbeta Hulikova; Claudiu T Supuran; Kieran Clarke; Richard D Vaughan-Jones; Damian J Tyler; Pawel Swietach
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

5.  Characterization of CA XV, a new GPI-anchored form of carbonic anhydrase.

Authors:  Mika Hilvo; Martti Tolvanen; Amy Clark; Bairong Shen; Gul N Shah; Abdul Waheed; Piia Halmi; Milla Hänninen; Jonna M Hämäläinen; Mauno Vihinen; William S Sly; Seppo Parkkila
Journal:  Biochem J       Date:  2005-11-15       Impact factor: 3.857

6.  Differential expression of cytoplasmic carbonic anhydrases, CA I and II, and membrane-associated isozymes, CA IX and XII, in normal mucosa of large intestine and in colorectal tumors.

Authors:  A J Kivela; J Saarnio; T J Karttunen; J Kivelä; A K Parkkila; S Pastorekova; J Pastorek; A Waheed; W S Sly; T S Parkkila; H Rajaniemi
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

7.  Regulation of high glucose-induced apoptosis of brain pericytes by mitochondrial CA VA: A specific target for prevention of diabetic cerebrovascular pathology.

Authors:  Tulin O Price; Nader Sheibani; Gul N Shah
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-01-26       Impact factor: 5.187

8.  Topiramate treatment protects blood-brain barrier pericytes from hyperglycemia-induced oxidative damage in diabetic mice.

Authors:  Tulin O Price; Vijay Eranki; William A Banks; Nuran Ercal; Gul N Shah
Journal:  Endocrinology       Date:  2011-11-22       Impact factor: 4.736

9.  Targeted mutagenesis of mitochondrial carbonic anhydrases VA and VB implicates both enzymes in ammonia detoxification and glucose metabolism.

Authors:  Gul N Shah; Timothy S Rubbelke; Joshua Hendin; Hien Nguyen; Abdul Waheed; James D Shoemaker; William S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-15       Impact factor: 11.205

10.  Pharmacological inhibition of mitochondrial carbonic anhydrases protects mouse cerebral pericytes from high glucose-induced oxidative stress and apoptosis.

Authors:  Gul N Shah; Tulin O Price; William A Banks; Yoichi Morofuji; Andrej Kovac; Nuran Ercal; Christine M Sorenson; Eui S Shin; Nader Sheibani
Journal:  J Pharmacol Exp Ther       Date:  2012-12-17       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.